You just read:

New Outcomes Data Using Delcath's Melphalan/HDS To Treat Unresectable Metastatic Ocular Melanoma To The Liver Accepted For Oral Presentation At Regional Cancer Therapies Symposium

News provided by

Delcath Systems, Inc.

Jan 18, 2017, 08:00 ET